238 related articles for article (PubMed ID: 34549454)
1. Comparison of O-RADS, GI-RADS, and ADNEX for Diagnosis of Adnexal Masses: An External Validation Study Conducted by Junior Sonologists.
Lai HW; Lyu GR; Kang Z; Li LY; Zhang Y; Huang YJ
J Ultrasound Med; 2022 Jun; 41(6):1497-1507. PubMed ID: 34549454
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the risk of malignancy in adnexal masses: validation of O-RADS and comparison with ADNEX model, SA, and RMI.
Wang R; Yang Z
Ginekol Pol; 2023; 94(10):799-806. PubMed ID: 36929789
[TBL] [Abstract][Full Text] [Related]
3. Comparative Study of the Efficacy of the Ovarian-Adnexa Reporting and Data System Ultrasound Combined With Contrast-Enhanced Ultrasound and the ADNEX MR Scoring System in the Diagnosis of Adnexal Masses.
Wang T; Cui W; Nie F; Huang X; Huang L; Liu L; Zhu Y; Zheng R
Ultrasound Med Biol; 2023 Sep; 49(9):2072-2080. PubMed ID: 37321953
[TBL] [Abstract][Full Text] [Related]
4. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
Hiett AK; Sonek JD; Guy M; Reid TJ
Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
[TBL] [Abstract][Full Text] [Related]
6. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses.
Basha MAA; Metwally MI; Gamil SA; Khater HM; Aly SA; El Sammak AA; Zaitoun MMA; Khattab EM; Azmy TM; Alayouty NA; Mohey N; Almassry HN; Yousef HY; Ibrahim SA; Mohamed EA; Mohamed AEM; Afifi AHM; Harb OA; Algazzar HY
Eur Radiol; 2021 Feb; 31(2):674-684. PubMed ID: 32809166
[TBL] [Abstract][Full Text] [Related]
7. Gynecology Imaging Reporting and Data System (GI-RADS): diagnostic performance and inter-reviewer agreement.
Basha MAA; Refaat R; Ibrahim SA; Madkour NM; Awad AM; Mohamed EM; El Sammak AA; Zaitoun MMA; Dawoud HA; Khamis MEM; Mohamed HAE; El-Maghraby AM; Abdalla AAEM; Assy MM; Nada MG; Obaya AA; Abdelbary EH
Eur Radiol; 2019 Nov; 29(11):5981-5990. PubMed ID: 30993433
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions.
Chen GY; Hsu TF; Chan IS; Liu CH; Chao WT; Shih YC; Jiang LY; Chang YH; Wang PH; Chen YJ
Eur Radiol; 2022 Nov; 32(11):7854-7864. PubMed ID: 35583711
[TBL] [Abstract][Full Text] [Related]
9. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
[TBL] [Abstract][Full Text] [Related]
10. Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer.
Pozzati F; Sassu CM; Marini G; Mascilini F; Biscione A; Giannarelli D; Garganese G; Fragomeni SM; Scambia G; Testa AC; Moro F
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):594-602. PubMed ID: 37204769
[TBL] [Abstract][Full Text] [Related]
11. External Validation of O-RADS US Risk Stratification and Management System.
Hack K; Gandhi N; Bouchard-Fortier G; Chawla TP; Ferguson SE; Li S; Kahn D; Tyrrell PN; Glanc P
Radiology; 2022 Jul; 304(1):114-120. PubMed ID: 35438559
[TBL] [Abstract][Full Text] [Related]
12. Comparison of International Ovarian Tumor Analysis ADNEX model and Ovarian-Adnexal Reporting and Data System with final histological diagnosis in adnexal masses: a retrospective study.
Filiz AA; Kahyaoglu S; Atalay CR
Obstet Gynecol Sci; 2024 Jan; 67(1):86-93. PubMed ID: 37822234
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparative trial comparing O-RADS, IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer.
Poonyakanok V; Tanmahasamut P; Jaishuen A
J Obstet Gynaecol Res; 2023 May; 49(5):1412-1417. PubMed ID: 36895122
[TBL] [Abstract][Full Text] [Related]
14. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
[TBL] [Abstract][Full Text] [Related]
15. O-RADS Classification for Ultrasound Assessment of Adnexal Masses: Agreement between IOTA Lexicon and ADNEX Model for Assigning Risk Group.
Vara J; Pagliuca M; Springer S; Gonzalez de Canales J; Brotons I; Yakcich J; Ajossa S; Pascual MA; Guerriero S; Alcazar JL
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832161
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
Zhang Q; Dai X; Li W
AJR Am J Roentgenol; 2023 Jul; 221(1):21-33. PubMed ID: 36722758
[No Abstract] [Full Text] [Related]
17. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX: a Portuguese multicenter study.
Borges AL; Brito M; Ambrósio P; Condeço R; Pinto P; Ambrósio B; Mahomed F; Gama JMR; Bernardo MJ; Gouveia AI; Djokovic D
Ultrasound Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38477149
[TBL] [Abstract][Full Text] [Related]
18. Predictive accuracy and reproducibility of the O-RADS US scoring system among sonologists with different training levels.
Wu M; Zhang M; Cao J; Wu S; Chen Y; Luo L; Lin X; Su M; Zhang X
Arch Gynecol Obstet; 2023 Aug; 308(2):631-637. PubMed ID: 35994107
[TBL] [Abstract][Full Text] [Related]
19. Simple rules, O-RADS, ADNEX and SRR model: Single oncologic center validation of diagnostic predictive models alone and combined (two-step strategy) to estimate the risk of malignancy in adnexal masses and ovarian tumors.
Spagnol G; Marchetti M; De Tommasi O; Vitagliano A; Cavallin F; Tozzi R; Saccardi C; Noventa M
Gynecol Oncol; 2023 Oct; 177():109-116. PubMed ID: 37660412
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound Assessment of Adnexal Pathology: Standardized Methods and Different Levels of Experience.
Tavoraitė I; Kronlachner L; Opolskienė G; Bartkevičienė D
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
